Barlevy Dorit, Furrer Rémy A, Kalapatapu Asha, Martinez Abigail, Lencz Todd, Carmi Shai, Lázaro-Muñoz Gabriel, Pereira Stacey
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX.
Department of Neurosurgery, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Genet Med. 2025 Sep;27(9):101507. doi: 10.1016/j.gim.2025.101507. Epub 2025 Jun 21.
Polygenic embryo screening (PES) estimates an embryo's genetic chances of developing complex conditions (eg, cancer) and traits (eg, height). Stakeholders have raised concerns that PES promotes eugenic practices and ideology.
We surveyed a nationally representative sample of the US public on approval of screening embryos for 12 conditions and 12 traits and examined the association between disapproval and concern about eugenics. We also conducted semistructured interviews with US-based reproductive endocrinology and infertility specialists and patients undergoing in vitro fertilization on their perspectives toward PES.
Among the US public (n = 1423), disapproval of screening embryos for traits has a stronger association with concern that PES promotes eugenics than disapproval of screening embryos for conditions. Interviews with reproductive endocrinology and infertility specialists (n = 27) and patients undergoing in vitro fertilization (n = 26) suggest that perceptions of PES as eugenic were more common when discussing screening and selecting for or against traits versus selecting against conditions.
Results suggest PES for traits is more frequently associated with eugenics and perceived often as unacceptable, whereas PES for conditions is perceived sometimes as acceptable. Future research should explore whether the distinction between conditions and traits is meaningful in the definition of eugenics and/or approval of genomics-based embryo selection and how that influences clinical practices and policy.
多基因胚胎筛查(PES)可评估胚胎发生复杂疾病(如癌症)和性状(如身高)的遗传几率。利益相关者担心PES会助长优生学实践和意识形态。
我们对具有全国代表性的美国公众样本进行了调查,了解他们对针对12种疾病和12种性状筛查胚胎的认可情况,并研究了不认可与对优生学的担忧之间的关联。我们还对美国的生殖内分泌学和不孕症专家以及接受体外受精的患者进行了半结构化访谈,了解他们对PES的看法。
在美国公众(n = 1423)中,与不认可针对疾病筛查胚胎相比,不认可针对性状筛查胚胎与更担心PES助长优生学的关联更强。对生殖内分泌学和不孕症专家(n = 27)以及接受体外受精的患者(n = 26)的访谈表明,在讨论针对性状进行筛查和选择(支持或反对)与针对疾病进行选择时,将PES视为优生学的看法更为常见。
结果表明,针对性状的PES更常与优生学相关联,且常被视为不可接受,而针对疾病的PES有时被视为可接受。未来的研究应探讨疾病和性状之间的区别在优生学定义和/或基于基因组学的胚胎选择认可中是否有意义,以及这如何影响临床实践和政策。